1 tic agents dichloroacetate and paclitaxel or HIV envelope protein gp120.

2 ls via anti-CD4 antibody or immune-complexed HIV envelope protein gp120.

3 ding network of a recombinant monomer of the HIV envelope protein gp120.

4 ype and p53 deficient mice to the neurotoxic HIV envelope protein gp120.

5 tive ligands, MIP-1beta/SDF-1alpha or by the HIV envelope protein, gp120.

6 okines in the spinal cord induced by a major HIV-envelope protein, gp120.

7             This study demonstrates that the HIV envelope protein, gp120, activates human arterial sm

8   SP-D has been shown to bind to HIV via the HIV envelope protein gp120 and inhibit infectivity in vi

9              In this study, a complex of the HIV-envelope protein gp120 and its cellular receptor CD4

10  are recognized by 2G12 as tightly as is the HIV envelope protein gp120, and they are the first const

11                                              HIV envelope protein gp120 exerts axonal toxicity direct

12  binding of CV-N to the heavily glycosylated HIV envelope protein gp120 is carbohydrate-dependent.

13                   To initiate HIV entry, the HIV envelope protein gp120 must engage its primary recep

14 body (MoAb) or human immunodeficiency virus (HIV) envelope protein gp120 reduces the expression of th

15 otective in vitro against two strains of the HIV envelope protein gp120 that binds to CXCR4 or CCR5.

16  act as inhibitors to prevent the binding of HIV envelope protein gp120 to DC-SIGN at nanomolar conce